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evaluate the impact of a new procedure to manage the
“birth path” technology (“. . . women should be encour-
aged to deliver in the position they ﬁnd more confort-
able”). We compared the traditional deliver-care path
(consisting in making women deliver in lithotomic posi-
tion) with a new one re-engineered according to the rec-
ommendations of the Cochrane Library, to let women
choose the deliver position. We evaluated three aspects of
healthcare quality: maternal and foetal clinical outcomes
(with logistic regression models), the costs of the new
healthcare process (with Activity Based Costing) and cus-
tomer satisfaction (with a satisfaction survey). RESULTS:
The study involved 430 women, without documented risk
factors for complicated pregnancy or delivery. Outcome
analysis: the probability that the delivery has a perineal
wound as outcome almost doubles if the patient does not
choose the labour position (OR = 2.396, CI 95% =
1.523–3.771); besides, a higher risk to develop a large
wound is associated to a foetal weight >3000g at expul-
sion (OR = 1.859, CI 95% = 1.135–3.047), together 
with the ﬁrst vaginal delivery (OR = 3.295, CI 95% =
1.982–5.478) and when the woman is more than 30 years
old (OR = 1.944, CI 95% = 1.257–3.007 (p < 0.01). Eco-
nomic evaluation: the costs for patient for free position
deliveries were slightly higher (range US$679.00 to
US$1893.00) than those for the traditional process
(ranged US$623.00–US$1737.00). Customer satisfaction:
overall satisfaction proved to be independent from the
presence of any complications, the humanisation level of
the structure, or the type of support, but it was inﬂuenced
by the possibility to choose the labour position and by
the woman’s expectations (p < 0.01). CONCLUSIONS:
Our ﬁndings led to the decision to change the traditional
process with the new one, the latter having similar 
costs and better outcomes. Nevertheless, this evaluation
process was complex.
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OBJECTIVES: Studies show that periconceptional folic
acid supplementation can prevent some neural tube
defects, the most common birth defects contributing to
infant mortality and severe disability. Despite widespread
campaigns to promote folic acid supplementation for
women of childbearing age, a recent national Gallup
survey found only 29% of women reported taking a mul-
tivitamin containing folic acid. The rate of supplementa-
tion is even lower among women with lower incomes and
education. The objective of this pilot study is to deter-
mine the effectiveness of direct-to-consumer strategies
targeted to increase folic acid use among women of 
childbearing age in a Medicaid managed care plan.
METHODS: A total of 2400 English-speaking women
(18–45 years old) enrolled in CareOregon were randomly
selected to receive one of 3 interventions: 1) folic acid
educational material plus a sample of multivitamins con-
taining folic acid and a voucher to redeem by mail for
multivitamins; 2) educational material plus a voucher to
redeem by mail for multivitamins containing folic acid;
and 3) educational material only. Vitamins were sent free
of charge to subjects through a mail-order pharmacy. 
Pre-and 3 month post-intervention surveys were used to
assess subjects’ folic acid use and knowledge. Prescription
claims for multivitamins and folic acid were evaluated
before and after intervention. RESULTS: The combined
pre- and post-intervention survey response rate for the 3
groups was 16.1%, 13.2%, and 11.9%, respectively. The
reported mean folic acid supplement use for the 3 groups
before intervention was 43%, 46%, and 37%, respec-
tively, and 59%, 62%, and 37%, respectively, after inter-
vention. Folic acid supplement use increased signiﬁcantly
(p < 0.01) for the voucher and vitamin groups, but not
for the educational material only group. CONCLU-
SIONS: Providing easier access to multivitamins through
direct marketing signiﬁcantly increases folic acid supple-
ment use after three months in women in a Medicaid 
population.
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OBJECTIVE: A patient assistance program (PAP) pro-
vided women with the option to have their levonorgestrel
implants (Norplant System) removed at no cost, but the
PAP only received half of patient-requested removal cer-
tiﬁcates (vouchers) for reimbursement. The primary goal
of this study was to examine the reasons for apparent
underutilization of the certiﬁcates and to identify treat-
ment barriers. METHODS: The study population in this
cross-sectional study was made up of women with the lev-
onorgestrel implant who requested removal certiﬁcates
from the Norplant Foundation during a seven-month
period, but did not return completed certiﬁcates via their
physicians. A total of 1820 women qualiﬁed for the
removal program during the 6-month data collection
period. Seventy-ﬁve percent of these women agreed to
participate in the study. A 3 page self-report questionnaire
and a return envelope were mailed to each participant,
with a single follow-up sent to non-responders within two
weeks of the initial mailing. The survey covered the
patient’s current removal status and possible reasons for
non-removal. RESULTS: Thirty-nine percent of the ques-
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tionnaires were successfully completed (N = 538). Of
respondents, 81% had already had their implant removed
by the time of the survey. Furthermore, the vast major-
ity of these women (91%) stated that they did turn in
removal certiﬁcates to their physicians. Those who did
not have their implant removed cite a variety of reasons,
usually personal time constraints and difﬁculty identify-
ing a provider. CONCLUSION: Providers appear to be
retaining removal certiﬁcates in their ofﬁces, creating the
perception that women are not obtaining removals. This
is likely due to the known contributing factors of low
reimbursement rates and the administrative burden to
obtain reimbursement. This study emphasizes the impor-
tance of using follow-up studies in patient programs to
ascertain reasons for program underutilization and to
guide program revisions.
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OBJECTIVES: Communication of decision analytic
models is limited by their complexity and cumbersome
computation requirements, lack of end-users’ experience
and familiarity with modeling techniques, and/or access
to dedicated software applications. We explored whether
second-order Monte-Carlo simulation (MCS) and regres-
sion techniques could be used to simplify complex deci-
sion trees and facilitate their use and modiﬁcation by end
users. METHODS: This analysis was based on a previ-
ously developed 4-cycle Markov-chain model project-
ing the one-year cost utility of a continuous combined
hormone replacement therapy (CCHRT) vs. no therapy
in women with menopausal symptoms. Using the model,
we conducted 1000 MCS to project the net incremental
QALYs, costs, and net monetary beneﬁt (NMB) associ-
ated with CCHRT. Results of the MCS were summarized
using OLS regressions, in which incremental QALYs and
costs were separately predicted using the model’s inputs.
These predictors and their coefﬁcients were then used to
back-predict the NMB of CCHRT. Multiple tests were
conducted to determine the predictive abilities of the
regression. RESULTS: The net cost and QALY regressions
were associated with R2 of 0.998 and 0.880, respectively.
The model and the regression estimated the net costs asso-
ciated with CCHRT to be $400.92 and $402.53, respec-
tively. The net estimated QALY gains were 0.0380 and
0.0356, respectively. In simultaneous runs of the model
and the regression, both approaches produced concor-
dant conclusions regarding the cost-effectiveness of
CCHRT in >95% of cases (kappa >0.78; P < 0.001).
CONCLUSIONS: MCS and regression techniques can 
be combined to meaningfully and successfully simplify
complex decision trees into reduced, empirical forms.
More broadly, the regression representation may be more
universally adopted by end users, who can readily adapt
it, using basic algebra, to approximate the results of the
original decision tree to their own settings. Hopefully, 
this representation could expand appreciation of cost-
effectiveness analyses on the part of end users.
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OBJECTIVES: Hysterectomy is one of the most com-
mon surgical procedures performed, with about 600,000
surgeries a year. Studies have found that although lap-
aroscopically-assisted vaginal hysterectomies (LAVH)
offer patients shorter recovery periods, they are also 
more resource-intensive. One way to offer patients 
the improved outcome of LAVH without substantially
increasing costs, is to provide it in an outpatient setting.
This research project compares resource utilization result-
ing from the use of LAVH in outpatient versus inpatient
settings. METHODS: Patients having a laparoscopically-
assisted vaginal hysterectomy performed in Florida hos-
pitals and outpatient surgical centers during 2000 were
selected from patient-level data collected by the Florida
Agency for Health Care Administration. Patients were
excluded from the analysis if they had cancer or if they
were under 18 and over 80 years of age. For resource 
utilization analysis, multiple regression was used to com-
pare non-physician costs across both hospital inpatients
and outpatients controlling for patient characteristics.
RESULTS: In 2000, there were 3225 laparoscopically-
assisted vaginal hysterectomies performed in hospitals
and outpatient surgical centers that met our inclusion cri-
teria. Of those surgeries, most (78.4%) were performed
in a hospital. Regression results indicate that resource uti-
lization was signiﬁcantly lower for patients in the outpa-
tient setting, even after controlling for complicating
conditions such as prolapse, adhesions and leiomyomas.
Charges in the outpatient setting are about $4500 lower
than a similar procedure in the hospital. CONCLU-
SIONS: Although not all hysterectomies are appropriately
performed in the outpatient setting, it is clear that
resources can be saved by switching settings for uncom-
plicated cases. Before recommendations can be made,
further research is required to assess patients transferred
into the hospital after attempting outpatient surgery, 
and to compare patient satisfaction across the two 
settings.
